⌕
Qiagen · QGEN · NYSE
Tenet 56 · Mixed
Compare
$49.75−0.12%At closeTenet 56 · Mixed
$49.75−0.06 (−0.12%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Qiagen (QGEN) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is QGEN's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Zacks Investment ResearchNov 13, 2026 · 10:16 ET
Interpreting Qiagen (QGEN) International Revenue Trends

Review Qiagen's (QGEN) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.…

QGEN −0.1% todayRead at source ↗
● Seeking AlphaNov 6, 2026 · 14:14 ET
Qiagen N.V. (QGEN) Shareholder/Analyst Call Prepared Remarks Transcript

Qiagen N.V. ( QGEN ) Shareholder/Analyst Call November 6, 2026 8:00 AM EST Company Participants Roland Sackers - CFO, MD & Member of Management Board Presentation Roland Sackers CFO, MD & Member of Management Board Good …

QGEN −0.1% todayRead at source ↗
● Business WireNov 6, 2026 · 10:00 ETCOMPANY'S OWN WORDS
QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director

VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that shareholders overwhelmingly approved the appointment of Jonathan M. Pratt as a Managing Director and membe…

QGEN −0.1% todayRead at source ↗
● Zacks Investment ResearchNov 4, 2026 · 22:01 ET
Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the…

QGEN −0.1% todayRead at source ↗
● Zacks Investment ResearchNov 4, 2026 · 20:46 ET
Qiagen (QGEN) Surpasses Q3 Earnings and Revenue Estimates

Qiagen (QGEN) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.64 per share a year ago.…

QGEN −0.1% todayRead at source ↗
● Business WireNov 4, 2026 · 16:05 ETCOMPANY'S OWN WORDS
QIAGEN Reports Full Q3 2026 Results

VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced full results for the third quarter of 2026, with net sales and adjusted diluted earnings per …

QGEN −0.1% todayRead at source ↗
● Zacks Investment ResearchOct 31, 2026 · 15:35 ET
Do Options Traders Know Something About Qiagen Stock We Don't?

Investors need to pay close attention to QGEN stock based on the movements in the options market lately.…

QGEN −0.1% todayRead at source ↗
● Zacks Investment ResearchOct 28, 2026 · 11:01 ET
Qiagen (QGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

QGEN −0.1% todayRead at source ↗
● GlobeNewsWireOct 28, 2026 · 09:40 ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ultralife Corporation (Nasdaq – ULBI), QIAGEN N.V. (NYSE – QGEN), CCC Intelligent Solutions Holdings Inc. (Nasdaq – CCC), Penske Automotive Group, Inc. (NYSE – PAG)

BALA CYNWYD, Pa., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith…

QGEN −0.1% todayRead at source ↗
● GlobeNewsWireOct 22, 2026 · 17:03 ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: QIAGEN N.V. (NYSE – QGEN), Varonis Systems, Inc. (Nasdaq – VRNS), CCC Intelligent Solutions Holdings Inc. (Nasdaq – CCC), Penske Automotive Group, Inc. (NYSE – PAG)

BALA CYNWYD, Pa., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith…

QGEN −0.1% todayRead at source ↗
● BenzingaOct 22, 2026 · 12:37 ET
This Qiagen Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.…

QGEN −0.1% todayRead at source ↗
● Business WireOct 22, 2026 · 09:03 ET
QGEN Stock Alert: Halper Sadeh LLC is Investigating Whether QIAGEN N.V. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of QIAGEN N.V. (NYSE: QGEN) to the EQT XI fund for €46.50 in cash per share.Halper Sadeh encourages QIAGEN shareholders …

QGEN −0.1% todayRead at source ↗
● Business WireOct 21, 2026 · 17:44 ETCOMPANY'S OWN WORDS
QIAGEN reports preliminary Q3 2026 results

VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary third-quarter 2026 financial results. Net sales were $548 million at both reporte…

QGEN −0.1% todayRead at source ↗
● Business WireOct 21, 2026 · 17:43 ETCOMPANY'S OWN WORDS
QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer

VENLO, Netherlands & AMSTERDAM--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (“QIAGEN” or the “Company”) and the EQT XI fund (“EQT Private Equity”) today announced an agreement under which Cro…

QGEN −0.1% todayRead at source ↗
● Defense WorldOct 21, 2026 · 04:15 ET
Qiagen N.V. (NYSE:QGEN) Stock Has Consensus Target Price of $43.93 According to Brokerages

Shares of Qiagen N.V. (NYSE: QGEN - Get Free Report) have been assigned an average rating of "Hold" from the fourteen research firms that are presently covering the stock, Marketbeat.com reports. Nine investment analysts…

QGEN −0.1% todayRead at source ↗
● ReutersOct 20, 2026 · 14:55 ET
EQT in advanced talks to buy testing firm Qiagen, Bloomberg News reports

European molecular testing company Qiagen is in ​advanced talks to be acquired by Swedish buyout ‌firm EQT, Bloomberg News reported on Tuesday, citing people familiar with the matter.…

QGEN −0.1% todayRead at source ↗
● Defense WorldOct 20, 2026 · 03:37 ET
15,494 Shares of Qiagen N.V. $QGEN Bought by Cordatus Wealth Management LLC

Cordatus Wealth Management LLC acquired a new stake in Qiagen N.V. (NYSE: QGEN) during a recent quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 15,494 share…

QGEN −0.1% todayRead at source ↗
● Business WireOct 13, 2026 · 16:05 ET
QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis

VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) will bring together tuberculosis experts from around the world for the Global TB Clinical a…

QGEN −0.1% todayRead at source ↗
● Business WireOct 6, 2026 · 16:05 ET
QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery

VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new artificial intelligence (AI) capabilities to help researchers analyze c…

QGEN −0.1% todayRead at source ↗
● Zacks Investment ResearchOct 2, 2026 · 10:11 ET
QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel

QGEN expands its U.S. QIAstat-Dx portfolio with an FDA-cleared panel that detects gram-negative bacteria and resistance markers in about one hour.…

QGEN −0.1% todayRead at source ↗
● Defense WorldOct 1, 2026 · 03:48 ET
Qiagen N.V. $QGEN Shares Sold by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. cut its holdings in Qiagen N.V. (NYSE: QGEN) by 4.8% during a recent quarter, according to its most recent disclosure with the SEC. The institutional investor owned 359,532 shares of the c…

QGEN −0.1% todayRead at source ↗
● Business WireSep 28, 2026 · 01:30 ET
QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel

GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that U.S. laboratories now have access to the complete QIAstat-Dx bloodstre…

QGEN −0.1% todayRead at source ↗
● Defense WorldSep 26, 2026 · 04:15 ET
Qiagen N.V. (NYSE:QGEN) Stock Has Consensus Target Price of $43.51

Qiagen N.V. (NYSE: QGEN - Get Free Report) has been given an average rating of "Hold" by the fourteen brokerages that are covering the company, Marketbeat reports. Nine analysts have rated the stock with a hold recommend…

QGEN −0.1% todayRead at source ↗
Business Wire · Nov 4, 2026
Business Wire · Oct 21, 2026

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA29−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just QGEN · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.